The Eating Disorders Genetics Initiative 2 (EDGI2): study protocol
- PMID: 40419993
- PMCID: PMC12105188
- DOI: 10.1186/s12888-025-06777-5
The Eating Disorders Genetics Initiative 2 (EDGI2): study protocol
Abstract
Background: The Eating Disorders Genetics Initiative 2 (EDGI2) is designed to explore the role of genes and environment in anorexia nervosa, bulimia nervosa, binge-eating disorder, and avoidant/restrictive food intake disorder (ARFID) with a focus on broad population representation and severe and/or longstanding illness.
Methods: A total of 20,000 new participants (18,700 cases and 1,300 controls) will be ascertained from the United States (US), Mexico (MX), Australia (AU), Aotearoa New Zealand (NZ), Sweden (SE), and Denmark (DK). Comprehensive phenotyping and genotyping will be performed for participants in US, MX, AU, NZ, and SE using the EDGI2 questionnaire battery and participant saliva samples. In DK, case identification and genotyping will be through the National Patient Register and bloodspots archived near birth. Case-control and case-case genome-wide association studies will be conducted within EDGI2 and enhanced via meta-analysis with external data from the Eating Disorders Working Group of the Psychiatric Genomics Consortium (PGC-ED). Additional analyses will explore genetic correlations between eating disorders (EDs) and other psychiatric and metabolic traits, calculate polygenic risk scores (PRS), and leverage functional biology to evaluate clinical outcomes. Moreover, analyzing PRS for patient stratification and linking identified risk loci to clinically relevant phenotypes highlight the potential of EDGI2 for clinical translation.
Discussion: EDGI2 is a global expansion of the EDGI study to increase sample size, increase participant representation across multiple ancestral backgrounds, and to include ARFID. ED genetics research has historically lagged behind other psychiatric disorders, and EDGI2 is designed to rapidly advance the study of the genetics of the major EDs. Exploring EDs at both the diagnostic level and the symptom level will provide an unprecedented look at the genetic architecture underlying EDs.
Trial registration: EDGI2 is a registered clinical trial: clinicaltrials.gov NCT06594913. https://clinicaltrials.gov/study/NCT06594913 (posted September 19, 2024).
Keywords: Anorexia nervosa; Avoidant/restrictive food intake disorder; Binge-eating disorder; Bulimia nervosa; Genome-wide association; Psychiatric genetics.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Ethics approvals and consent to participate: This study is being conducted in accordance with the Helsinki Declaration of 1975, as revised in 2008. Ethical approval for EDGI2 study was obtained by the University of North Carolina at Chapel Hill Biomedical Institutional Review Board (IRB) (Protocol #23–2887); Research Ethics Committee of the School of Medicine of the Monterrey Institute of Technology and Higher Studies (folio: P000552-EDGI-MX- 2021-CEIC-CR009; QIMR Berghofer Human Research Ethics Committee (QIMRB-HREC approval P3550), New Zealand Health and Disability Ethics Committees (Ethics Reference: HDEC20/CEN/1/HDEC20/CEN/1_ 2024 AM 9136), the Swedish Ethical Review Authority (DNR: 2023–00254 - 02), and Danish Scientific Ethics Committee, the Danish Health Data Authority, the Danish data protection agency and the Danish Neonatal Screening Biobank Steering Committee. All participants from US, MX, NZ, AU, and SE will provide informed consent prior to engaging in any study-related activities. The electronic consent process was approved by the ethical committees. Consent for publication: Not applicable. Competing interests: CM Bulik receives royalties from Pearson Education, Inc. PF Sullivan reports Neumora Therapeutics (advisory committee, shareholder). L Dinkler received personal fees from Baxter Medical AB and Fresenius Kabi AB. All other authors report no financial interests or potential conflicts of interest.
References
-
- Termorshuizen J, Davies H, Lee S, Huckins L, Bulik C, Breen G, et al. Genome-wide association studies of binge-eating behaviour and anorexia nervosa yield insights into the unique and shared biology of eating disorder phenotypes. medRxiv. 2025. 10.1101/2025.01.31.25321397.
-
- Zickgraf HF, Ellis JM. Initial validation of the Nine Item Avoidant/Restrictive Food Intake disorder screen (NIAS): A measure of three restrictive eating patterns. Appetite. 2018;123:32–42. - PubMed
Publication types
MeSH terms
Associated data
Grants and funding
- R01MH136149/MH/NIMH NIH HHS/United States
- R01MH136149/MH/NIMH NIH HHS/United States
- R01MH136157/MH/NIMH NIH HHS/United States
- R01MH136149/MH/NIMH NIH HHS/United States
- R01MH136156/MH/NIMH NIH HHS/United States
- R01MH136157/MH/NIMH NIH HHS/United States
- R01MH136149/MH/NIMH NIH HHS/United States
- R01MH136149/MH/NIMH NIH HHS/United States
- R01MH136149/MH/NIMH NIH HHS/United States
- R01MH136149/MH/NIMH NIH HHS/United States
- R01MH136156/MH/NIMH NIH HHS/United States
- R01MH136156/MH/NIMH NIH HHS/United States
- R01MH136156/MH/NIMH NIH HHS/United States
- R01MH136149/MH/NIMH NIH HHS/United States
- R01MH136157/MH/NIMH NIH HHS/United States
- R01MH136157/MH/NIMH NIH HHS/United States
- R01MH136149/MH/NIMH NIH HHS/United States
- R01MH136157/MH/NIMH NIH HHS/United States
- R01MH136156/MH/NIMH NIH HHS/United States
- R01MH136149/MH/NIMH NIH HHS/United States
- R01MH136156/MH/NIMH NIH HHS/United States
- R01MH136149/MH/NIMH NIH HHS/United States
- R01MH136149/MH/NIMH NIH HHS/United States
- R01MH136156/MH/NIMH NIH HHS/United States
- R01MH136149/MH/NIMH NIH HHS/United States
- R01MH136149/MH/NIMH NIH HHS/United States
- R01MH136149/MH/NIMH NIH HHS/United States
- R01MH136149/MH/NIMH NIH HHS/United States
- R01MH136149/MH/NIMH NIH HHS/United States
- R01MH136149/MH/NIMH NIH HHS/United States
- R01MH136156/MH/NIMH NIH HHS/United States
- R01MH136156/MH/NIMH NIH HHS/United States
- R01MH136156/MH/NIMH NIH HHS/United States
- R01MH136157/MH/NIMH NIH HHS/United States
- R01MH136157/MH/NIMH NIH HHS/United States
- R01MH136157/MH/NIMH NIH HHS/United States
- R01MH136149/MH/NIMH NIH HHS/United States
- R01MH136156/MH/NIMH NIH HHS/United States
- R01MH136156/MH/NIMH NIH HHS/United States
- R01MH136157/MH/NIMH NIH HHS/United States
- R01MH136149/MH/NIMH NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical